Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-17-011785)

Filing Details

Accession Number:: 0001179110-17-011785
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-08-23 18:04:52
Reporting Period:: 2017-08-21

Accepted Time:: 2017-08-23 17:04:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1583107	Theravance Biopharma Inc.	TBPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1597334	Frank Pasqualone	C/O Theravance Biopharma Us, Inc. 901 Gateway Blvd South San Francisco CA 94080	Svp, Chief Comm Ops Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2017-08-21	4,000	$26.34	213,180	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average purchase price per share for the open market purchase on August 21, 2017. The shares were purchased at prices ranging from $26.2499 to $26.4541 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.